Recordati SpA (MIL:REC) Tax Rate %: 23.76% (As of Mar. 2026)


MIL:REC Recordati SpA MIL:REC
95 GF Score
Price €51.30
GF Value €60.81
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Tax Rate %?

Recordati SpA MIL:REC -0.58% 95 Tax Rate % is 23.76% as of Mar. 2026. GuruFocus rates MIL:REC with a GF Score™ of 95/100 and a GF Value™ of €60.81 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Recordati SpA's Tax Expense for the three months ended in Mar. 2026 was €48 Mil. Recordati SpA's Pre-Tax Income for the three months ended in Mar. 2026 was €201 Mil. Therefore, Recordati SpA's Tax Rate % for the quarter that ended in Mar. 2026 was 23.76%.

Recordati SpA Tax Rate % Related Terms

Recordati SpA Tax Rate % Historical Data

* Premium members only.

The historical data trend for Recordati SpA's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Tax Rate % Chart

Recordati SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.70 22.20 20.74 23.88 23.68

Recordati SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.15 23.78 24.00 22.79 23.76
MIL:REC
95GF Score
Recordati SpA MIL:REC
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recordati SpA Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Recordati SpA's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=137.65/581.274
=23.68 %

Recordati SpA's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=47.69/200.751
=23.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 23.76% mean?
Recordati SpA (MIL:REC) has a Tax Rate % of 23.76% as of Mar. 2026.
Is Recordati SpA's Tax Rate % too high?
Recordati SpA's current Tax Rate % is 23.76%. Overall, Recordati SpA has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Tax Rate % compare to LLY and JNJ?
Recordati SpA's Tax Rate % of 23.76% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Drug Manufacturers company?
A good Tax Rate % depends on the Drug Manufacturers industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Recordati SpA's current Tax Rate % is 23.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MIL:REC) is currently considered Modestly Undervalued. The stock's GF Value™ is €60.81, compared to a current price of €51.30 — trading 15.6% below its estimated fair value. The current Tax Rate % is 23.76%. Recordati SpA's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Recordati SpA (MIL:REC), the current Tax Rate % is 23.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MIL:REC) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of €51.30 is trading 15.6% below its estimated GF Value™ of €60.81. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MIL:REC:

  • Tax Rate %: 23.76%
  • GF Value™: €60.81 vs. price of €51.30 (15.6% below fair value)
  • GF Score™: 95/100 with 3 warning signs

No single metric tells the full story. See the MIL:REC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
95GF Score

Get the complete analysis for MIL:REC

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.30
Price
€60.81
GF Value